Jazz Pharmaceuticals shares tumble on earnings miss, weak 2024 guidance

Published on 27 Feb 2024 on Investing.com

Jazz Pharmaceuticals plc (NASDAQ: JAZZ ) today reported financial results for the fourth quarter of...

Read the rest of the article

Start tracking your investments with Statfolio

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is a fast-growing pharmaceutical company headquartered in ...

GuruFocus.com via Yahoo Finance 14 Mar 2024

In this article, we will take a look at the 10 biotech stocks with huge potential. To skip our an...

Insider Monkey via Yahoo Finance 8 Mar 2024

In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. Fo...

Insider Monkey via Yahoo Finance 7 Mar 2024

Jazz Pharmaceuticals JAZZ reported adjusted earnings of $5.02 per share in fourth-quarter 2023, m...

Zacks via Yahoo Finance 29 Feb 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript February 28, 2024 Jazz Ph...

Insider Monkey via Yahoo Finance 29 Feb 2024

Total Revenues: $3.8 billion in 2023, with a 27% year-over-year increase from key growth drivers....

GuruFocus.com via Yahoo Finance 28 Feb 2024

Jazz Pharmaceuticals plc (NASDAQ: JAZZ ) today reported financial results for the fourth quarter ...

Investing.com 27 Feb 2024

On Wednesday, the company announced that Ed Clark, head of its 737 program and an 18-year Boeing...

Fortune 22 Feb 2024

Jazz Pharmaceuticals names Philip Johnson as new CFO

Investing.com 21 Feb 2024

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP1...

Benzinga via Yahoo Finance 22 Dec 2023